Key financial ranges
Market cap · USD equivalent−∞—+∞
P/E ratio−∞—+∞
Annual revenue · USD equivalent−∞—+∞
Revenue growth−∞—+∞
5,601–5,620 of 6,553
CompanyMarket capP/ERevenueRev. growthNet incomeCashDebtAI value
RDHLRedHill Biopharma Ltd.$4.33M—$8.04M+23.2%-$8.27M$2.87M$214KAI pending
CVKDCadrenal Therapeutics, Inc.$4.32M————$2.39M$2.23KAI pending
XRTXXORTX Therapeutics Inc.$4.32M————CA$18.85M—AI pending
CETXCemtrex Inc$4.32M—$76.49M+14.4%-$28.11M$7.97M$19.75MAI pending
CSAICloudastructure, Inc.$4.31M—$5.07M+271.3%-$8.46M$3.81M—AI pending
BGLCBioNexus Gene Lab Corp$4.31M—$7.42M-21.9%-$2.98M$1.23M$198.59KAI pending
AUMNGolden Minerals Co$4.31M0.9×$12M-48.5%-$9.23M$2.5M$18KAI pending
AREBAmerican Rebel Holdings Inc$4.29M—$9.52M-16.6%-$34.33M$96.46K$16.45MAI pending
AGMHAgm Group Holdings, Inc.$4.27M0.2×$30.56M-4.6%$561.63K$325.34K$3.92MAI pending
CNEYCn Energy Group. Inc.$4.26M—$35.57M-30.2%-$11.14M$390.71K$0AI pending
HIHOHighway Holdings Ltd$4.25M—$57K-99.2%-$1.52M$4.41M$3.16MAI pending
CVSICV Sciences, Inc.$4.25M—$13.79M-12.2%-$958K$266K$236KAI pending
TCRTAlaunos Therapeutics, Inc.$4.22M—$5K-50.0%-$4.18M$124K$0AI pending
EMMAEmmaus Life Sciences, Inc.$4.21M—$12.45M-25.2%-$7.49M$2.81M$26.69MAI pending
CUENCuentas Inc.$4.21M—$676K-71.2%-$3.31M$1K$713KAI pending
ELABPMGC Holdings Inc.$4.19M—$590.08K-65.5%-$7.75M$18.14M$5.16MAI pending
GPLLGPL Holdings, Inc.$4.17M————$9.13K—AI pending
PAVSParanovus Entertainment Technology Ltd.$4.14M—$14.6M+20,310.9%-$12.73M$10.3M$237.64KAI pending
DFSCDEFSEC Technologies Inc.$4.13M—CA$1.5M+21.9%-CA$7.44MCA$256.83KCA$302.22KAI pending
APGHAleeanPeace Group Holdings Ltd$4.13M—$328.34K-40.1%-$302.83K$447—AI pending